Micro RNA 506 Blocks Ovarian Cancer Cells

Researchers employing an extensive analysis of genomic information have identified micro RNA 506 (miR-506) as a potential therapeutic candidate for advanced or metastatic ovarian cancer situations. This high-risk cohort of ovarian cancer patients can be tested in mouse models of the disease to try and find better treatments.  read more

Read the whole article on

More from